OakChart

Materialise Nv ADR

MTLSTechnology·Software - Application·Belgium·Small·NASD·Nov 11 • 11:50 AM ET

6.89-0.03 (-0.46%)
2026-11-11 17:52 CET
Market cap
398.87 USD m
Revenue, TTM
318.53 USD m
Net income, TTM
14.81 USD m
Free cash flow, TTM
23.11 USD m
EPS diluted, TTM
0.25
P/E
27.32
Compare

Price

MTLS against its 20, 50 and 200-day averages
2050200earnings
5.006.007.008.009.00625K1.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MTLSclose 6.8920-day 7.6150-day 7.84200-day 6.446.8952w high

21.9% under the 52-week high of 8.82 on 29 Sep 2026. 52-week low 4.78 on 27 Mar 2026. Last 15 sessions, 38.3% high to low

Profile

MTLS
52-week range, 52% of the way up
4.788.82

Materialise NV engages in the provision of additive manufacturing software and 3D printing services. It operates through the following segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software worldwide through programs and platforms that enable companies to set up reliable and sustainable 3D printing production. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services to industrial and commercial customers. The company was founded by Wilfried Vancraen and Hilde Ingelaere on June 28, 1990 and is headquartered in Leuven, Belgium.

Employees2556
IPOJun 25, 2014
Beta1.30
ATR, 14d0.35
Rel volume0.12
Inst own14.48%

Snapshot

6 groups

Valuation

Index-
Market Cap397.05M
Enterprise Value303.28M
Income14.81M
Sales318.53M
Book/sh5.04
Cash/sh3.03
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees2556
IPOJun 25, 2014

Ratios

P/E27.32
Forward P/E25.31
PEG0.74
P/S1.25
P/B1.37
P/C2.28
P/FCF17.18
EV/EBITDA9.07
EV/Sales0.95
Quick Ratio2.33
Current Ratio2.52
Debt/Eq0.28
LT Debt/Eq0.24
Option/ShortYes / Yes

Earnings

EPS (ttm)0.25
EPS next Y0.27
EPS next Q0.06
EPS this Y44.78%
EPS next Y29.50%
EPS next 5Y34.10%
EPS past 3/5Y- -
Sales past 3/5Y7.39% 9.22%
EPS Y/Y TTM-7.75%
Sales Y/Y TTM9.52%
EPS Q/Q-25.41%
Sales Q/Q0.55%
EarningsOct 28 BMO
EPS/Sales Surpr.-4.29% -5.79%

Ownership

Insider Own-
Insider Trans-
Inst Own14.48%
Inst Trans0.98%
ROA3.03%
ROE5.05%
ROIC4.09%
Gross Margin57.44%
Oper. Margin2.13%
Profit Margin4.65%
SMA20-9.54%
SMA50-12.18%
SMA2006.96%
Trades-

Technical

Shs Outstand57.64M
Shs Float-
Short Float-
Short Ratio2.46
Short Interest0.48M
52W High8.82 -21.90%
52W Low4.78 44.11%
Volatility5.54% 4.68%
ATR (14)0.35
RSI (14)37.12
Beta1.30
Rel Volume0.12
Avg Volume195.75K
Volume9,526

Performance

Perf Week-5.89%
Perf Month-15.27%
Perf Quarter0.42%
Perf Half Y23.23%
Perf YTD24.12%
Perf Year16.16%
Perf 3Y23.45%
Perf 5Y-72.10%
Perf 10Y2.20%
Recom1.67
Target Price9.92
Prev Close6.92
Price6.89
Change %-0.46%

Analyst ratings

latest 10 of 12
DateActionAnalystRating changeTargetImplied
Apr 24, 2024InitiatedCCantor FitzgeraldOverweight$9.50+37.9%
May 26, 2023UpgradeKKeplerHold → Buy$11+59.7%
Mar 25, 2022DowngradeBBryan GarnierBuy → Neutral$20+190.3%
Oct 20, 2021InitiatedJJP MorganOverweight$28+306.5%
Sep 02, 2021InitiatedSStifelBuy$30+335.5%
Aug 09, 2021InitiatedLLake StreetBuy$30+335.5%
Mar 10, 2021UpgradeBBryan GarnierNeutral → Buy$43+524.2%
Oct 30, 2020ResumedPPiper SandlerNeutral$38+451.6%
Apr 07, 2020DowngradePPiper SandlerOverweight → Neutral$20 → $15.50+125.0%
Jan 10, 2020DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight

Peers

Mkt cap
TickerCompanyMkt cap
DDD3D Systems Corp309.41M
SSYSStratasys Ltd572.89M
NNDMNano Dimension Ltd ADR275.40M
PTCPTC Inc21.28B
ADSKAutodesk Inc53.58B
VELOVelo3D Inc161.87M
PRLBProto Labs Inc1.66B
BSYBentley Systems Inc13.49B
XMTRXometry Inc7.20B
ZBHZimmer Biomet Holdings Inc20.13B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Idem, a Belgium civil partnersDirectorNov 20 '25Proposed Sale6.02590,0003,551,800Nov 20 04:21 PM

Held by

AUM
TickerCompanyAUM
PRNTARK 3D Printing ETFAUM: 54.45M
APIEActivePassive International Equity ETFAUM: 1.13B
GWXState Street SPDR S&P International Small Cap ETFAUM: 906.57M
BULDPacer BlueStar Engineering the Future ETFAUM: 8.33M
SPDWState Street SPDR Portfolio Developed World ex-US ETFAUM: 41.64B

News

latest 14 of 206
  • Materialise: Q3 Earnings Snapshot (Associated Press) -21.35%
  • Materialise Holds Its Guidance As Profits Slip, Growth Cools And A Stock Rally Leaves Little Room For A Soft Fourth Quarter (Earnings Whispers)
  • Materialise Reports Third Quarter 2026 Results (Business Wire)
  • Materialise Must Prove Its Profit Inflection Holds As Software Weakness Lingers (Earnings Whispers)
  • Materialise NV to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 (Business Wire)
  • Loading…
  • Materialise NV (MTLS) (Q2 2026) Earnings Call Highlights: Medical Growth and Aerospace Surge ... (GuruFocus.com) +11.24% -5.39%
  • Materialise: Q2 Earnings Snapshot (Associated Press)
  • Materialise Reports Second Quarter and Half-Year 2026 Results (Business Wire)
  • Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions (GlobeNewswire)
  • MATERIALISE NV RESULTS OF ANNUAL GENERAL SHAREHOLDERS' MEETING OF 16 JUNE 2026 (GlobeNewswire)
  • Materialise to Hold Annual Shareholders' Meeting on June 16, 2026 (GlobeNewswire)
  • Materialise: Q1 Earnings Snapshot (Associated Press)
  • Materialise Reports First Quarter 2026 Results (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-280.0220.0230.05675.2979.921
2026Q22026-08-270.0700.0460.06681.6780.471
2026Q12026-05-070.0350.0120.03677.8678.631
2025Q42026-02-190.1300.0700.12282.7182.461
2025Q32025-10-280.0350.0120.03777.2076.511
2025Q22025-07-240.0000.0240.00476.3378.881
2025Q12025-04-24-0.011-0.042-0.01075.2065.761
2024Q42025-02-200.0520.0520.24368.4474.421
2024Q32024-10-240.0540.0270.05774.0172.312
2024Q22024-07-310.0760.0490.07174.4172.852
2024Q12024-04-250.064-0.0050.06668.0966.962
2023Q42024-02-21-0.0110.066-0.01070.5070.211
2023Q32023-10-260.0740.0110.07463.6270.021
2023Q22023-07-26-0.0110.055-0.00971.6672.931
2023Q12023-04-270.066-0.0760.06872.6964.681
2022Q42023-02-14-0.0860.022-0.07967.0368.422

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-0.037-0.070-0.040176.79173.85
2018FY0.0680.1020.061209.06208.78
2019FY0.0330.0560.030219.12222.82
2020FY-0.155-0.092-0.136202.55202.05
2021FY0.2540.1930.274227.28222.6
2022FY-0.0430.027-0.038248.03253.34
2023FY0.1190.1970.123276.87283.98
2024FY0.2400.2180.246277.99283.26
2025FY0.1530.0980.152315.5312.54
2026FY-0.210--312.18
2027FY-0.272--330.77
2028FY-0.350--354.77

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1020081.3879.6683.10
2026Q4S2026-10-2820180.7179.0082.41
2026Q4S2026-09-0320183.8881.9285.83
2026Q4S2026-08-2710182.4082.4082.40
2026Q4S2026-05-0710085.8785.8785.87
2026Q4S2026-05-0510084.6584.6584.65
2026Q4S2026-02-1910185.3585.3585.35
2026Q4S2025-11-1110090.1890.1890.18
2026Q4S2025-11-1010090.1890.1890.18
2026Q4S2025-11-0910090.1890.1890.18
2026Q4S2025-11-0810090.1890.1890.18
2026Q4S2025-11-0710090.1890.1890.18
2026Q4S2025-11-0610090.1890.1890.18
2026Q4S2025-11-0510090.1890.1890.18

Estimate history

EPS, annual-0.040.0610.03-0.1360.274-0.0380.1230.2460.1470.2521
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0570.243-0.010.0040.0370.1220.0360.0660.027
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual160.813217.925220.133194.308242.838243.85276.903288.557302.045318.53
Period201720182019202020212022202320242025TTM
Sales, quarterly75.41770.0669.86173.48377.43281.66677.53881.47577.856
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual59.06759.06759.06759.06759.06459.06759.06759.06759.06757.64
Period201720182019202020212022202320242025MRQ
Shares, quarterly59.06759.06759.06759.06759.06759.06758.556-57.64
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue318.53302.04288.56276.90243.85242.84194.31220.13217.92
Cost of Goods Sold Incl. D&A135.57140.59136.32130.94119.92114.0696.14106.79105.80
Gross Profit182.97161.45152.23145.97123.93128.7898.17113.34112.13
Selling, General and Administrative Excl. Other176.18159.59150.30137.66134.60121.13104.82113.55114.09
Research and Development57.0650.4246.1939.6137.2529.3625.2224.4725.47
Other Operating Expense--1.03-1.35-1.47-0.93-0.88-1.37-0.74-0.83
Operating Income6.792.893.289.78-9.748.53-5.290.53-1.13
Interest Expense-2.341.792.262.923.363.423.192.50
Unusual Expense-0.000.0010.180.170.485.680.00-0.23
Net Income Before Taxes14.578.2215.297.32-1.2416.24-9.335.184.63
Income Taxes-0.25-0.480.790.081.020.70-1.172.900.50
Consolidated Net Income14.828.7114.507.24-2.2615.54-8.201.843.57
Net Income From Continuing Operations14.818.7114.537.27-2.2315.55-8.031.783.57
Net Income14.818.7114.537.27-2.2315.55-8.031.783.57
EPS (Recurring)0.260.150.250.24-0.040.28-0.070.030.06
EPS (Basic, Before Extraordinaries)0.250.150.250.12-0.040.27-0.140.030.06
EPS (Diluted)0.250.150.250.12-0.040.27-0.140.030.06
EBITDA33.4427.4726.7532.9313.4132.7817.1422.1119.26
Non-Operating Income (Expense)11.797.6713.819.9911.5911.555.067.848.04
Other After Tax Adjustments-0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.480.230.230.03-0.11-0.920.610.24-
Price To Earnings Ratio27.4327.4338.32122.7165.4892.09-556.53967.63
Price To Sales Ratio1.561.091.441.402.135.5916.484.915.43
Gross Margin57.4453.4552.7652.7150.8253.0350.5251.4951.45
Operating Margin2.130.961.143.53-3.993.51-2.720.24-0.52
Net Margin4.652.885.042.62-0.916.40-4.130.811.64
Shares Outstanding57.6459.0759.0759.0759.0759.0659.0759.0759.07
Market Capitalization398.87398.87415.83387.78519.761,408.332,883.66968.43947.93

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue77.8681.4777.5481.6777.4373.4869.8670.06
Cost of Goods Sold Incl. D&A32.9535.2333.2134.1933.4330.6631.2131.27
Gross Profit44.9146.2544.3347.4844.0042.8238.6538.79
Selling, General and Administrative Excl. Other44.0143.9042.9545.3242.0941.1838.4341.59
Research and Development14.7314.3213.9114.1013.3712.6012.0112.91
Other Operating Expense0.00-0.000.000.000.000.000.00
Operating Income0.902.351.382.161.911.640.23-2.80
Interest Expense1.301.010.82-0.684.582.920.46
Unusual Expense0.88-0.000.000.000.000.000.00
Net Income Before Taxes1.733.522.906.412.81-0.36-0.322.17
Income Taxes0.14-0.350.78-0.810.65-0.590.25-0.93
Consolidated Net Income1.593.872.137.222.160.23-0.563.10
Net Income From Continuing Operations1.583.872.137.222.160.23-0.563.11
Net Income1.583.872.137.222.160.23-0.563.11
EPS (Recurring)0.040.070.040.120.040.00-0.010.05
EPS (Basic, Before Extraordinaries)0.030.070.040.120.040.00-0.010.24
EPS (Diluted)0.030.070.040.120.040.00-0.010.24
EBITDA7.049.807.998.618.337.506.003.07
Non-Operating Income (Expense)3.002.182.344.261.582.582.385.43
Other After Tax Adjustments0.00-0.000.000.000.000.000.00
Stock Option Compensation Expense0.310.050.050.060.060.040.060.06
Price To Earnings Ratio27.4337.36-66.3953.7633.1220.0038.32
Price To Sales Ratio1.561.360.941.081.131.161.001.44
Gross Margin57.6856.7657.1758.1456.8258.2755.3355.37
Operating Margin1.162.881.782.642.462.230.32-4.00
Net Margin2.034.752.758.842.790.31-0.804.44
Shares Outstanding57.64-58.5659.0759.0759.0759.0759.07
Market Capitalization398.87435.07291.79327.82329.00333.73290.61415.83

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments157.28105.94140.92150.34222.92136.47144.69132.0451.84
Short Term Receivables75.7068.2663.3859.0354.0444.4452.7147.7649.52
Inventories17.5017.6018.8217.1612.8412.2914.2511.4213.24
Other Current Assets5.07-------0.00
Total Current Assets255.55191.79223.12226.53289.81193.20211.65191.22114.60
Net Property, Plant & Equipment138.92123.28114.33109.60106.33121.45114.04105.78104.55
Total Investments and Advances0.000.000.000.330.454.703.464.341.00
Long-Term Note Receivable0.004.134.143.734.057.593.24-0.97
Intangible Assets80.8075.9782.4387.5557.3163.1152.7650.0955.42
Deferred Tax Assets4.663.653.091.270.260.250.220.360.37
Other Assets14.0911.5911.039.9211.918.486.836.275.86
Total Assets494.03410.41438.14438.92470.13398.78392.20358.06281.80
Short Term Debt Incl. Current Port. of LT Debt12.1313.4628.1521.3024.1121.4418.9015.5415.33
Accounts Payable23.6424.1823.4124.7922.9421.6520.7921.3418.82
Income Tax Payable0.881.481.961.330.891.193.772.642.43
Other Current Liabilities71.2766.6962.4165.8356.0459.0450.8844.0538.77
Total Current Liabilities107.91105.81115.93113.25103.98103.3294.3483.5875.35
Long Term Debt62.0029.2942.9965.1288.59119.40124.71105.6798.21
Provision for Risks Charges0.470.891.581.720.760.390.140.090.13
Deferred Tax Liabilities3.123.324.114.604.976.106.457.128.90
Other Liabilities20.4713.7912.179.907.346.626.296.146.68
Total Liabilities193.98153.09176.78194.60205.64235.83231.93202.61189.27
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity300.14257.40261.41244.35264.49162.96156.60155.4692.53
Total Shareholders Equity300.14257.40261.41244.35264.49162.96156.60155.4692.53
Accumulated Minority Interest-0.09-0.09-0.06-0.030.000.003.680.000.00
Total Equity300.05257.31261.35244.32264.49162.96160.27155.4692.53
Total Liabilities & Stockholders Equity494.03410.41438.14438.92470.13398.78392.20358.06281.80
Book Value Per Share2.542.182.212.072.241.381.331.320.78
Tangible Book Value Per Share3.713.073.032.653.511.691.761.780.63
Full-Time Employees2,5562,5142,4372,4332,3322,1622,1772,0091,862
Price to Book Ratio1.371.511.552.245.3318.036.216.816.69
Return on Assets1.933.431.66-0.493.57-2.030.471.11-1.06
Return on Equity3.125.602.87-0.887.28-5.031.142.87-2.72
Return on Invested Capital2.415.072.39-0.724.40-2.840.631.37-1.25
Quick Ratio2.211.651.761.852.661.752.092.151.35
Current Ratio2.371.811.922.002.791.872.242.291.52

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income14.648.7114.507.24-2.2615.54-8.201.843.57
Depreciation26.6224.5023.5923.3222.9824.2922.4321.5820.39
Other Funds (Non Cash)-0.073.42-3.982.94-0.46-5.063.102.081.00
Funds from Operations40.9436.6234.1133.5020.2634.7617.3325.1325.90
Extraordinary Item-0.000.000.000.000.000.000.000.00
Changes in Working Capital-8.50-9.98-1.53-13.601.08-6.9614.264.105.90
Cash from Operating Activities32.4526.6432.5819.9021.3327.8031.5929.2331.79
Capital Expenditures-11.57-18.35-28.53-12.71-26.04-13.86-20.12-17.53-23.72
Net Assets From Acquisitions-0.570.00-2.890.00-30.79-1.03-9.16-7.090.00
Sale of Fixed Assets and Businesses0.600.440.500.780.220.550.630.310.33
Purchase or Sale of Investments-0.010.000.000.000.000.00-0.34-1.29-3.15
Purchase of Investments-0.010.000.000.000.000.00-0.34-1.29-3.15
Sale Or Maturity of Investments-0.000.000.000.000.000.000.000.00
Other Uses-0.530.000.000.000.00-1.18-3.23-3.070.00
Other Sources8.916.960.000.00-0.000.000.000.00
Cash from Investing Activities-3.17-10.95-30.92-11.93-56.61-15.52-32.22-28.67-26.54
Cash Dividends Paid-0.000.000.000.000.000.000.000.00
Change in Capital Stock-8.460.000.000.000.02104.154.691.4266.64
Repurchase of Common Pref Stock-8.460.000.000.000.000.000.000.000.00
Sale of Common Pref Stock-0.000.000.000.02104.154.691.4266.64
Proceedsfrom Stock Options-0.000.000.000.02104.154.691.4266.64
Issuance or Reduction of Debt, Net-27.02-25.17-18.08-18.61-16.88-15.6618.8912.54
Net Financing Active Other Cash Flow-0.77-2.420.09-0.370.574.04-1.550.23-0.18
Other Financing Activities Uses--2.420.00-0.370.000.00-1.550.00-0.18
Cash from Financing Activities-4.8421.14-28.46-22.29-21.5786.85-16.6714.6379.01
Exchange Rate Effect0.67-1.16-0.53-0.05-1.130.74-2.49-0.201.07
Net Change in Cash25.1035.68-27.33-14.37-57.9799.87-19.7914.9985.33
Free Cash Flow23.1110.745.929.92-1.3818.4219.0114.1510.24
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow21.5130.5370.3339.12-73.66168.4276.42115.54
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00-0.370.93

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments174.39152.90153.19157.28155.13137.00
Short Term Receivables55.4164.2263.9075.7052.7558.18
Inventories19.7819.2619.3017.5018.4217.23
Other Current Assets15.0516.5422.025.0725.7924.30
Total Current Assets264.63252.92258.41255.55252.09236.71
Net Property, Plant & Equipment131.75132.22135.28138.92138.54138.68
Total Investments and Advances0.010.470.000.004.910.00
Intangible Assets74.3476.0178.0780.8082.0183.34
Deferred Tax Assets4.684.754.424.664.024.41
Other Assets12.0711.136.0514.096.656.70
Total Assets487.93477.52482.23494.03488.23474.69
Short Term Debt Incl. Current Port. of LT Debt9.7110.5811.1012.1312.6012.49
Accounts Payable23.7722.1622.7923.6422.1623.58
Income Tax Payable0.531.071.000.880.460.66
Other Current Liabilities71.2171.3371.9271.2771.2372.86
Total Current Liabilities105.22105.13106.82107.91106.45109.58
Long Term Debt71.0057.4758.1762.0062.9250.51
Provision for Risks Charges0.000.000.000.470.000.00
Deferred Tax Liabilities2.662.822.963.123.323.43
Other Liabilities18.5019.1019.7820.4720.1718.39
Total Liabilities197.37184.52187.73193.98192.87181.92
Non-Equity Reserves0.00-0.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity290.65293.09294.59300.14295.45292.86
Total Shareholders Equity290.65293.09294.59300.14295.45292.86
Accumulated Minority Interest-0.09-0.10-0.10-0.09-0.09-0.09
Total Equity290.56292.99294.50300.05295.36292.77
Total Liabilities & Stockholders Equity487.93477.52482.23494.03488.23474.69
Book Value Per Share5.04-5.032.542.502.48
Tangible Book Value Per Share3.75-3.703.713.613.55
Full-Time Employees---2,556--
Price to Book Ratio1.372.971.981.111.121.24
Return on Assets3.033.232.602.001.061.36
Return on Equity5.055.254.173.251.732.21
Return on Invested Capital0.441.100.601.990.600.07
Quick Ratio2.332.222.242.212.202.00
Current Ratio2.522.412.422.372.372.16

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income1.573.892.137.042.070.20
Depreciation6.127.496.616.396.625.81
Other Funds (Non Cash)-0.14-0.270.000.33-0.443.48
Funds from Operations7.7010.769.5212.978.868.92
Extraordinary Item--0.000.000.000.00
Changes in Working Capital2.77-1.83-1.98-7.452.52-9.05
Cash from Operating Activities10.468.937.545.5211.38-0.13
Capital Expenditures-2.47-2.31-1.72-5.07-6.22-5.20
Net Assets From Acquisitions0.00-0.570.000.000.000.00
Sale of Fixed Assets and Businesses-0.060.400.080.180.010.17
Purchase or Sale of Investments0.00-0.010.000.000.000.00
Purchase of Investments0.00-0.010.000.000.000.00
Sale Or Maturity of Investments--0.000.000.000.00
Other Uses-0.07-0.470.000.000.000.00
Other Sources4.660.010.273.970.152.87
Cash from Investing Activities2.06-2.95-1.37-0.92-6.07-2.16
Cash Dividends Paid--0.000.000.000.00
Preferred Dividends (Cash Flow)--0.000.000.000.00
Change in Capital Stock-2.34-3.40-2.710.000.000.00
Repurchase of Common Pref Stock-2.34-3.40-2.710.000.000.00
Sale of Common Pref Stock--0.000.000.000.00
Proceedsfrom Stock Options--0.000.000.000.00
Issuance or Reduction of Debt, Net13.56-0.57-4.05-0.5213.3818.98
Net Financing Active Other Cash Flow-0.06-0.000.02-0.72-0.30-1.08
Other Financing Activities Uses--0.00-0.72-0.29-1.09
Cash from Financing Activities10.29-5.34-7.62-2.1812.2117.08
Exchange Rate Effect0.200.210.38-0.13-0.04-0.73
Net Change in Cash23.020.85-1.062.2917.4914.06
Free Cash Flow8.676.806.401.245.79-4.76
Price to Free Cash Flow21.5121.4233.5030.4240.98164.38

Revenue breakdown

Manufacturing2024: 115.24M 2025: 104.32M
Medical devices and services2024: 89.37M 2025: 109.34M
Software (medical)2024: 36.52M 2025: 42.07M
Software (non-medical)2024: 47.50M 2025: 46.14M
Americas exclusing US2024: 7.05M 2025: 7.04M
Asia Pacific2024: 19.56M 2025: 21.80M
Belgium2024: 7.10M 2025: 6.94M
France2024: 18.78M 2025: 19.39M
Germany2024: 37.83M 2025: 34.84M
Italy2024: 9.07M 2025: 9.20M
Netherlands2024: 8.57M 2025: 8.41M
Rest of Europe2024: 24.94M 2025: 29.20M
Switzerland2024: 21.33M 2025: 23.07M
United Kingdom2024: 16.92M 2025: 16.90M
United States2024: 117.48M 2025: 125.07M
Materialise Manufacturing2024: 115.24M 2025: 104.32M
Materialise Medical2024: 125.89M 2025: 151.41M
Materialise Software2024: 47.50M 2025: 46.14M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-30-0.5M-188.07K
2026-10-15-0.5M-148.65K
2026-09-30-0.5M-123.85K
2026-09-15-0.4M-107.62K
2026-08-31-0.3M-113.61K
2026-08-14-0.4M-115.74K
2026-07-31-0.4M-128.65K
2026-07-15-0.4M-131.00K
2026-06-30-0.4M-129.21K
2026-06-150.63%0.4M59.1M119.19K
2026-05-290.61%0.4M59.1M102.03K
2026-05-150.56%0.3M59.1M103.44K
2026-04-300.60%0.4M59.1M99.81K
2026-04-150.66%0.4M59.1M107.35K
2026-03-310.64%0.4M59.1M131.54K
2026-03-130.74%0.4M59.1M133.10K
2026-02-270.69%0.4M59.1M147.72K
2026-02-130.65%0.4M59.1M140.71K
2026-01-300.53%0.3M59.1M151.25K
2026-01-150.49%0.3M59.1M167.22K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.503.905.105.508.8181.000.000.975-0.0140.001
call5.001.602.352.373.1031250.000.935-0.0120.001
call7.500.000.300.051.1943430.000.373-0.0280.004
call10.000.000.100.051.7684460.000.119-0.0210.002
put2.500.000.750.003.9100.000.00-0.025-0.0140.001
put5.000.000.050.053.50727.000.00-0.195-0.0580.003
put7.500.200.950.501.38033.000.00-0.525-0.0520.004
put10.002.403.603.353.1231.000.00-0.881-0.0200.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-09SEC
2026-11-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-02SEC
2026-10-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-29SEC
2026-10-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-28SEC
2026-10-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-26SEC
2026-10-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-19SEC
2026-10-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-13SEC
2026-10-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-05SEC
2026-09-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-28SEC
2026-09-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-21SEC
2026-09-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-14SEC
2026-09-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-08SEC
2026-08-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-28SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-27SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-27SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-27SEC
2026-07-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-27SEC
2026-07-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-20SEC
2026-07-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-13SEC
2026-07-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-06SEC
2026-06-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-29SEC
2026-06-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-22SEC
2026-06-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-15SEC
2026-06-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-08SEC
2026-06-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-01SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-26SEC
2026-05-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-18SEC
2026-05-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-15SEC
2026-05-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-11SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
DISCIPLINED GROWTH INVESTORS INC /MN3.40%
Rock Point Advisors, LLC1.69%
ACADIAN ASSET MANAGEMENT LLC1.38%
Archon Capital Management LLC1.31%
KING LUTHER CAPITAL MANAGEMENT CORP1.01%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.81%
ARK Investment Management LLC0.72%
RENAISSANCE TECHNOLOGIES LLC0.51%
CITADEL ADVISORS LLC0.42%
EDMOND DE ROTHSCHILD HOLDING S.A.0.33%

Funds

Fund% owned
The 3D Printing ETF0.58%
Pacer BlueStar Engineering the Future ETF0.07%
ActivePassive International Equity ETF0.05%
State Street(R) SPDR(R) S&P(R) International Small Cap ETF0.04%
SIIT WORLD EQUITY EX-US FUND0.03%
Fidelity Nasdaq Composite Index Fund0.02%
TETON Westwood Mighty Mites Fund0.02%
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF0.02%
Parametric International Equity Fund0.01%
VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND0.01%

OakChart. MTLS. Cached 15 minutes.